HepQuant Announces Approval of Fourth Investigational Device Exemption Application HepQuant SHUNT™ Liver Diagnostic Kit for use in a clinical study in subjects with Alcoholic Hepatitis DENVER (September 14, 2017) — HepQuant,... read more →
HepQuant Completes Third State-Sponsored Grant State of Colorado funding enables advancement of supply chain, regulatory advancements and HepQuant laboratory DENVER (August 31, 2017) — HepQuant, LLC, a diagnostics company, located... read more →
HepQuant Test Inventor and Founder Doctor Gregory T. Everson Accepts Position of CEO DENVER (July 1, 2017) — HepQuant, LLC, a Greenwood Village, Colo.-based company with a unique, patented and patent-pending... read more →